Literature DB >> 10771231

Two year results: sharp versus rounded optic edges on silicone lenses.

A J Kruger1, J Schauersberger, C Abela, G Schild, M Amon.   

Abstract

To evaluate the role of optic edge design of 2 silicone intraocular lenses (IOLs) in 2 year clinical results. Department of Ophthalmology, University of Vienna, Medical School, Allgemeines Krankenhaus, Austria. In this comparative clinical study, 50 eyes had phacoemulsification and implantation of a high-refractive 3-piece silicone IOL with sharp optic edges (CeeOn model 911F) (n = 25) or a 3-piece silicone lens with rounded optic edges (CeeOn model 920) (n = 25). Biomicroscopic findings, including those of specular microscopic examination of the anterior lens surface, were documented and the results analyzed. After 2 years, a significant between-group difference in posterior capsule opacification (PCO) but not in anterior capsule alterations was observed. Behind all CeeOn 911F sharp-edge IOLs, the capsule remained clear; in 2 of 23 capsules behind the CeeOn 920 rounded-edge, a neodymium: YAG laser capsulotomy had to be performed for dense central fibrotic PCO. Seven of 21 of the remaining eyes had first-degree central fibrotic PCO, 14 of 23 had peripheral mixed fibrotic and slender Elschnig pearl PCO, and 8 of 23 had second-degree peripheral PCO. Specular microscopic findings did not differ between the 2 groups. No severe IOL decentration occurred in any eye; 25% in the sharp-edge group and 40% in the rounded-edge group had minimal decentration. The silicone IOL with the sharp optic edge design was associated with significantly reduced PCO 2 years postoperatively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771231     DOI: 10.1016/s0886-3350(00)00323-0

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  13 in total

1.  Posterior capsule opacification after implantation of a hydrogel intraocular lens.

Authors:  K Hayashi; H Hayashi
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

2.  Systems of analysis of posterior capsule opacification.

Authors:  T M Aslam; B Dhillon; N Werghi; A Taguri; A Wadood
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

3.  [Influence of intraocular lens material and design on the development of posterior capsule opacification].

Authors:  O Nishi
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

Review 4.  [New methods for the prevention of posterior capsule opacification].

Authors:  G U Auffarth; T M Rabsilber; A J Reuland
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

5.  Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.

Authors:  K A Becker; M Martin; T M Rabsilber; B B Entz; A J Reuland; G U Auffarth
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

6.  [Secondary increase in intraocular pressure after complication-free cataract operation with implantation of the posterior chamber lens].

Authors:  D Kook; T Kohnen
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

7.  Accommodation after Nd: YAG capsulotomy in patients with accommodative posterior chamber lens 1CU.

Authors:  Nhung X Nguyen; B Seitz; S Reese; A Langenbucher; M Küchle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-14       Impact factor: 3.117

8.  Comparison of 25-gauge sutureless vitrectomy and 20-gauge vitrectomy in the treatment of posterior capsule opacification in pseudophakic children.

Authors:  Xiao-Ming Wu; Li-Xin Xie
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

9.  Posterior capsule morphology determinants of visual function.

Authors:  Tariq Mehmood Aslam; Peter Aspinall; Baljean Dhillon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-20       Impact factor: 3.117

10.  Cost of cataract surgery after implantation of three intraocular lenses.

Authors:  Catherine Boureau; Antoine Lafuma; Viviane Jeanbat; Andrew F Smith; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2009-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.